Shandong China – October 28, 2026 – HYRT, a global designer and manufacturer of precision micro-irrigation systems, today shared milestone performance updates highlighting the international adoption and reliability of its agricultural
San Mateo, CA, USA – October 28, 2026 – Ming Sing Floral Water, a Taiwanese heritage brand celebrating its 120th anniversary in 2026, will make its U.S. debut at the
The Key Chondrosarcoma Companies in the market include – Servier, Inhibrx, and others. (Albany, US), October 28, 2026 – DelveInsight’s ‘Chondrosarcoma Market Insights, Epidemiology and Market Forecast – 2036’ report
The Key Hemophilia B Companies in the market include – Centessa Pharmaceuticals, Sanofi (Genzyme), Alnylam Pharmaceuticals, Pfizer, Spark Therapeutics, Be Biopharma, Equilibra Bioscience, Regeneron Pharmaceuticals, Intellia Therapeutics, Novo Nordisk, and
The Key Metastatic HER2 Positive Breast Cancer Companies in the market include – Byondis, Roche, Pfizer, Ambrx, Bolt Biotherapeutics, BioInvent International AB, Klus Pharma, DualityBio, Artiva Biotherapeutics, Vaccinex, Suzhou Zanrong
The Key Influenza A Companies in the market include – Roche, BioCryst Pharmaceuticals, Seqirus, Moderna, Merck, GlaxoSmithKline, Cocrystal Pharma, and others. (Albany, US), October 28, 2026 – DelveInsight’s ‘Influenza A
The Diabetic Retinopathy clinical trial analysis report delivers important insights into ongoing research on 55+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 28, 2026
The Dry Eye Disease clinical trial analysis report delivers important insights into ongoing research on 60+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 28,
The Encephalopathy clinical trial analysis report delivers important insights into ongoing research on 55+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 28, 2026 –
The Cannabinoid Agonist clinical trial analysis report delivers important insights into ongoing research on 22+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 28, 2026
